We did have some concerns that (Theranos) could pick away at some profitable business in a way that would not be helpful to either of those companies' long-term growth profiles, it certainly hasn't hurt their stock prices that this hard-to-perfectly-handicap risk has become less of one.

Dave Perkins

Categorized in : Healthcare

Water started coming up out of the Gulf, tore up one of the buildings, roof came off, boat flipped over, pieces of debris are falling out of the air.

The stock looked inexpensive relative to our estimate of the company's intrinsic value, it feels like a pretty stable place to be.